This brand name is authorized in Canada, United Kingdom, United States
The drug ADDERALL contains a combination of these active pharmaceutical ingredients (APIs):
|
1
Dexamfetamine
UNII G83415V073 - DEXTROAMPHETAMINE SACCHARATE
|
|
Amphetamines are non-catecholamine, sympathomimetic amines with CNS stimulant activity. Peripheral actions include elevations of systolic and diastolic blood pressures and weak bronchodilator and respiratory stimulant action. |
|
2
Amfetamine
UNII O1ZPV620O4 - AMPHETAMINE ASPARTATE MONOHYDRATE
|
|
Amphetamine is a potent central nervous system (CNS) stimulant that is used in the treatment of attention deficit hyperactivity disorder (ADHD), narcolepsy, and obesity. Amphetamine properly refers to a specific chemical, the racemic free base, which is equal parts of the two enantiomers, levoamphetamine and dextroamphetamine, in their pure amine forms. Historically, it has been used to treat nasal congestion and depression. Amphetamine is also used as an athletic performance enhancer and cognitive enhancer, and recreationally as an aphrodisiac and euphoriant. |
|
3
Dexamfetamine
UNII TZ47U051FI - DEXTROAMPHETAMINE
|
|
Amphetamines are non-catecholamine, sympathomimetic amines with CNS stimulant activity. Peripheral actions include elevations of systolic and diastolic blood pressures and weak bronchodilator and respiratory stimulant action. |
|
4
Amfetamine
UNII 6DPV8NK46S - AMPHETAMINE SULFATE
|
|
Amphetamine is a potent central nervous system (CNS) stimulant that is used in the treatment of attention deficit hyperactivity disorder (ADHD), narcolepsy, and obesity. Amphetamine properly refers to a specific chemical, the racemic free base, which is equal parts of the two enantiomers, levoamphetamine and dextroamphetamine, in their pure amine forms. Historically, it has been used to treat nasal congestion and depression. Amphetamine is also used as an athletic performance enhancer and cognitive enhancer, and recreationally as an aphrodisiac and euphoriant. |
Below package inserts are available for further reading:
| Title | Information Source | Document Type | |
|---|---|---|---|
| ADDERALL XR Extended-release capsule | FDA, National Drug Code (US) | MPI, US: SPL/PLR |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| N06BA01 | Amfetamine | N Nervous system → N06 Psychoanaleptics → N06B Psychostimulants, agents used for ADHD and nootropics → N06BA Centrally acting sympathomimetics |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: CA | Health Products and Food Branch | Identifier(s): 02248808, 02248809, 02248810, 02248811, 02248812, 02248813 |
| Country: GB | Medicines & Healthcare Products Regulatory Agency | Identifier(s): 158349, 158352, 158469, 158470, 158471, 158472, 158473 |
| Country: US | FDA, National Drug Code | Identifier(s): 54092-381, 54092-383, 54092-385, 54092-387, 54092-389, 54092-391, 57844-105, 57844-110, 57844-112, 57844-115, 57844-117, 57844-120, 57844-130 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
